{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:01:29Z","timestamp":1777302089294,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.imlet.2021.01.006","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:22:56Z","timestamp":1610929376000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Oral co-administration of bivalent protein r-BL with U-Omp19 elicits mucosal immune responses and reduces S. Typhimurium shedding in BALB\/c mice"],"prefix":"10.1016","volume":"231","author":[{"given":"Pradnya Sukhadev","family":"Nikam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8799-5164","authenticated-orcid":false,"given":"Anil Kumar","family":"Belagal Motatis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2021.01.006_bib0005","series-title":"WHO Estimates of the Global Burden of Foodborne Diseases: Foodborne Disease Burden Epidemiology Reference Group 2007-2015","year":"2015"},{"key":"10.1016\/j.imlet.2021.01.006_bib0010","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1016\/j.vaccine.2010.07.061","article-title":"Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7","volume":"28","author":"Amani","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2021.01.006_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01043","article-title":"Plasma-derived polyreactive secretory-like IgA and IgM opsonizing Salmonella enterica typhimurium reduces invasion and gut tissue inflammation through agglutination","volume":"8","author":"Bioley","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.01.006_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00381","article-title":"Identification of protective antigens for vaccination against systemic salmonellosis","volume":"5","author":"Bumann","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.01.006_bib0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jconrel.2018.11.025","article-title":"Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier","volume":"293","author":"Coria","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.imlet.2021.01.006_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002933","article-title":"Host\u2013Pathogen interaction in invasive salmonellosis","volume":"8","author":"de Jong","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imlet.2021.01.006_bib0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-065X.2010.00999.x","article-title":"Immunity to salmonellosis","volume":"240","author":"Dougan","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2021.01.006_bib0040","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/21553769.2015.1051243","article-title":"Salmonella: A review on pathogenesis, epidemiology and antibiotic resistance","volume":"8","author":"Eng","year":"2015","journal-title":"Front. Life Sci."},{"key":"10.1016\/j.imlet.2021.01.006_bib0045","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.4014\/jmb.1512.12082","article-title":"Construction and immunogenicity of recombinant swinepox virus expressing outer membrane protein l of Salmonella","volume":"26","author":"Fang","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.imlet.2021.01.006_bib0050","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.173.7.4635","article-title":"Lipoproteins, Not Lipopolysaccharide, Are the Key Mediators of the Proinflammatory Response Elicited by Heat-KilledBrucella abortus","volume":"173","author":"Giambartolomei","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2021.01.006_bib0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1286-4579(01)01411-3","article-title":"Salmonella pathogenicity islands encoding type III secretion systems","volume":"3","author":"Hansen-Wester","year":"2001","journal-title":"Microbes Infect."},{"key":"10.1016\/j.imlet.2021.01.006_bib0060","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3201\/eid1106.041017","article-title":"Steen Ethelberg, international Salmonella typhimurium DT104 infections, 1992-2001","volume":"6","author":"Helms","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.imlet.2021.01.006_bib0065","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2021.01.006_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0171-2985(11)80473-0","article-title":"Mucosal Immunity: Implications for Vaccine Development","volume":"184","author":"Holmgren","year":"1992","journal-title":"Immunobiology"},{"key":"10.1016\/j.imlet.2021.01.006_bib0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00481","article-title":"Salmonella-host interactions-modulation of the host innate immune system","volume":"5","author":"Hurley","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.01.006_bib0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.10.011","article-title":"A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses","volume":"220","author":"Iba\u00f1ez","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.imlet.2021.01.006_bib0085","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1073\/pnas.1111413109","article-title":"Identification of a common immune signature in murine and human systemic Salmonellosis","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.imlet.2021.01.006_bib0090","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4049\/jimmunol.1601357","article-title":"Dual immunization with SseB\/Flagellin provides enhanced protection against Salmonella infection mediated by circulating memory cells","volume":"199","author":"Lee","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2021.01.006_bib0095","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2007.10.011","article-title":"Entry route of Salmonella typhimurium directs the type of induced immune response","volume":"27","author":"Martinoli","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2021.01.006_bib0100","series-title":"Salmonellosis, Encycl. Gastroenterol.","first-page":"384","author":"Mafi","year":"2020"},{"key":"10.1016\/j.imlet.2021.01.006_bib0105","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4161\/hv.6.12.13142","article-title":"Mucosal immunization: a realistic alternative","volume":"6","author":"Otczyk","year":"2010","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.imlet.2021.01.006_bib0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01436","article-title":"Omp19 enables Brucella abortus to evade the antimicrobial activity from host\u2019s proteolytic defense system","volume":"10","author":"Pasquevich","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.01.006_bib0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2217\/fmb.14.98","article-title":"Protective host immune responses to Salmonella infection","volume":"10","author":"Pham","year":"2015","journal-title":"Future Microbiol."},{"key":"10.1016\/j.imlet.2021.01.006_bib0120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/infdis\/jiw162","article-title":"Intranasal vaccination with Salmonella -Derived serodominant secreted effector protein B associated with gas-filled microbubbles partially protects against gut infection in mice","volume":"214","author":"Pigny","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imlet.2021.01.006_bib0125","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/imm.12327","article-title":"The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles","volume":"143","author":"Reynolds","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2021.01.006_bib0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00171","article-title":"U-Omp19 from Brucella abortus is a useful adjuvant for vaccine formulations against Salmonella infection in mice","volume":"8","author":"Risso","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.01.006_bib0135","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.vaccine.2014.01.044","article-title":"A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice","volume":"32","author":"Singh","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2021.01.006_bib0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/apm.12351","article-title":"Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles","volume":"123","author":"Srivastava","year":"2015","journal-title":"APMIS"},{"key":"10.1016\/j.imlet.2021.01.006_bib0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20052093","article-title":"Innate secretory antibodies protect against natural Salmonella typhimurium infection","volume":"203","author":"Wijburg","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2021.01.006_bib0150","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.vaccine.2013.04.044","article-title":"Identification and characterization of OmpL as a potential vaccine candidate for immune protection against salmonellosis in mice","volume":"31","author":"Yang","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2021.01.006_bib0155","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1016\/j.vaccine.2011.05.059","article-title":"Potential protective immunogenicity of recombinant Clostridium perfringens \u03b1\u2013\u03b22\u2013\u03b21 fusion toxin in mice, sows and cows","volume":"29","author":"Zeng","year":"2011","journal-title":"Vaccine"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:39:16Z","timestamp":1759045156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247821000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":31,"alternative-id":["S0165247821000067"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2021.01.006","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral co-administration of bivalent protein r-BL with U-Omp19 elicits mucosal immune responses and reduces S. Typhimurium shedding in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2021.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}